vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Natera, Inc. (NTRA). Click either name above to swap in a different company.
Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $359.9M, roughly 1.8× AdvanSix Inc.). Natera, Inc. runs the higher net margin — 7.1% vs -0.8%, a 7.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 9.4%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $36.1M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
ASIX vs NTRA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $665.5M |
| Net Profit | $-2.8M | $47.3M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | -3.4% |
| Net Margin | -0.8% | 7.1% |
| Revenue YoY | 9.4% | 39.8% |
| Net Profit YoY | -892.9% | 187.9% |
| EPS (diluted) | $-0.11 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $665.5M | ||
| Q3 25 | $374.5M | $592.2M | ||
| Q2 25 | $410.0M | $546.6M | ||
| Q1 25 | $377.8M | $501.8M | ||
| Q4 24 | $329.1M | $476.1M | ||
| Q3 24 | $398.2M | $439.8M | ||
| Q2 24 | $453.5M | $413.4M | ||
| Q1 24 | $336.8M | $367.7M |
| Q4 25 | $-2.8M | $47.3M | ||
| Q3 25 | $-2.6M | $-87.5M | ||
| Q2 25 | $31.4M | $-100.9M | ||
| Q1 25 | $23.3M | $-66.9M | ||
| Q4 24 | $352.0K | $-53.8M | ||
| Q3 24 | $22.3M | $-31.6M | ||
| Q2 24 | $38.9M | $-37.5M | ||
| Q1 24 | $-17.4M | $-67.6M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | -3.4% | ||
| Q3 25 | -0.9% | -16.5% | ||
| Q2 25 | 7.7% | -20.2% | ||
| Q1 25 | 7.7% | -15.8% | ||
| Q4 24 | -3.9% | -13.6% | ||
| Q3 24 | 7.5% | -8.9% | ||
| Q2 24 | 11.5% | -10.6% | ||
| Q1 24 | -7.0% | -20.2% |
| Q4 25 | -0.8% | 7.1% | ||
| Q3 25 | -0.7% | -14.8% | ||
| Q2 25 | 7.7% | -18.5% | ||
| Q1 25 | 6.2% | -13.3% | ||
| Q4 24 | 0.1% | -11.3% | ||
| Q3 24 | 5.6% | -7.2% | ||
| Q2 24 | 8.6% | -9.1% | ||
| Q1 24 | -5.2% | -18.4% |
| Q4 25 | $-0.11 | $0.36 | ||
| Q3 25 | $-0.10 | $-0.64 | ||
| Q2 25 | $1.15 | $-0.74 | ||
| Q1 25 | $0.86 | $-0.50 | ||
| Q4 24 | $0.02 | $-0.41 | ||
| Q3 24 | $0.82 | $-0.26 | ||
| Q2 24 | $1.43 | $-0.30 | ||
| Q1 24 | $-0.65 | $-0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.7B |
| Total Assets | $1.7B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | $1.0M | ||
| Q2 25 | $18.4M | $16.0M | ||
| Q1 25 | $8.3M | $17.8M | ||
| Q4 24 | $19.6M | $22.7M | ||
| Q3 24 | $17.3M | $29.5M | ||
| Q2 24 | $12.1M | $90.3M | ||
| Q1 24 | $20.6M | $69.1M |
| Q4 25 | $815.2M | $1.7B | ||
| Q3 25 | $818.2M | $1.3B | ||
| Q2 25 | $823.7M | $1.2B | ||
| Q1 25 | $794.4M | $1.2B | ||
| Q4 24 | $774.6M | $1.2B | ||
| Q3 24 | $766.4M | $878.5M | ||
| Q2 24 | $746.6M | $836.5M | ||
| Q1 24 | $713.2M | $794.1M |
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.8B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.5B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $73.9M |
| Free Cash FlowOCF − Capex | $36.1M | $37.8M |
| FCF MarginFCF / Revenue | 10.0% | 5.7% |
| Capex IntensityCapex / Revenue | 7.7% | 5.4% |
| Cash ConversionOCF / Net Profit | — | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $109.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $73.9M | ||
| Q3 25 | $26.6M | $59.4M | ||
| Q2 25 | $21.1M | $37.6M | ||
| Q1 25 | $11.4M | $44.5M | ||
| Q4 24 | $64.2M | $52.9M | ||
| Q3 24 | $57.3M | $51.8M | ||
| Q2 24 | $50.2M | $4.0M | ||
| Q1 24 | $-36.2M | $27.0M |
| Q4 25 | $36.1M | $37.8M | ||
| Q3 25 | $66.0K | $37.0M | ||
| Q2 25 | $-7.2M | $11.7M | ||
| Q1 25 | $-22.6M | $22.6M | ||
| Q4 24 | $29.8M | $34.8M | ||
| Q3 24 | $26.8M | $35.5M | ||
| Q2 24 | $16.7M | $-7.7M | ||
| Q1 24 | $-71.6M | $6.7M |
| Q4 25 | 10.0% | 5.7% | ||
| Q3 25 | 0.0% | 6.2% | ||
| Q2 25 | -1.7% | 2.1% | ||
| Q1 25 | -6.0% | 4.5% | ||
| Q4 24 | 9.1% | 7.3% | ||
| Q3 24 | 6.7% | 8.1% | ||
| Q2 24 | 3.7% | -1.9% | ||
| Q1 24 | -21.3% | 1.8% |
| Q4 25 | 7.7% | 5.4% | ||
| Q3 25 | 7.1% | 3.8% | ||
| Q2 25 | 6.9% | 4.7% | ||
| Q1 25 | 9.0% | 4.3% | ||
| Q4 24 | 10.4% | 3.8% | ||
| Q3 24 | 7.7% | 3.7% | ||
| Q2 24 | 7.4% | 2.8% | ||
| Q1 24 | 10.5% | 5.5% |
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
NTRA
Segment breakdown not available.
